Key result
Myristoylated PKC-ζ pseudosubstrate inhibited both insulin-stimulated and AMPK-mediated glucose and fatty acid uptake by >80% in both wild-type and PKC-λ-knockout cardiomyocytes.
Why the study?
Does atypical PKC inhibition reduce insulin-stimulated and AMPK-mediated glucose and fatty acid uptake in cardiomyocytes?
Does atypical PKC inhibition reduce insulin-stimulated and AMPK-mediated glucose and fatty acid uptake in cardiomyocytes?
Atypical PKCs are necessary for insulin- and AMPK-mediated glucose and fatty acid uptake in the heart, with PKC-λ and PKC-ζ having interchangeable functions.
Atypical PKCs are required for cardiomyocyte substrate uptake; leaves open translation to in vivo cardiac metabolism or human disease.
AIM: The signaling pathways involved in the regulation of cardiac GLUT4 translocation/glucose uptake and CD36 translocation/long-chain fatty acid uptake are not fully understood. We compared in heart/muscle-specific PKC-λ knockout mice the roles of atypical PKCs (PKC-ζ and PKC-λ) in regulating cardiac glucose and fatty acid uptake. RESULTS: Neither insulin-stimulated nor AMPK-mediated glucose and fatty acid uptake were inhibited upon genetic PKC-λ ablation in cardiomyocytes. In contrast, myristoylated PKC-ζ pseudosubstrate inhibited both insulin-stimulated and AMPK-mediated glucose and fatty acid uptake by >80% in both wild-type and PKC-λ-knockout cardiomyocytes. In PKC-λ knockout cardiomyocytes, PKC-ζ is the sole remaining atypical PKC isoform, and its expression level is not different from wild-type cardiomyocytes, in which it contributes to 29% and 17% of total atypical PKC expression and phosphorylation, respectively. CONCLUSION: Taken together, atypical PKCs are necessary for insulin-stimulated and AMPK-mediated glucose uptake into the heart, as well as for insulin-stimulated and AMPK-mediated fatty acid uptake. However, the residual PKC-ζ activity in PKC-λ-knockout cardiomyocytes is sufficient to allow optimal stimulation of glucose and fatty acid uptake, indicating that atypical PKCs are necessary but not rate-limiting in the regulation of cardiac substrate uptake and that PKC-λ and PKC-ζ have interchangeable functions in these processes.
No takes yet. Share an insight, caveat, or question.
Habets et al. (2012) studied Cardiac glucose and fatty acid uptake regulation. Myristoylated PKC-ζ pseudosubstrate vs. Vehicle control (0.35% DMSO) was evaluated on Insulin-stimulated and AMPK-mediated glucose and fatty acid uptake. Myristoylated PKC-ζ pseudosubstrate inhibited both insulin-stimulated and AMPK-mediated glucose and fatty acid uptake by >80% in both wild-type and PKC-λ-knockout cardiomyocytes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: